Skip to main content
. Author manuscript; available in PMC: 2024 Sep 4.
Published in final edited form as: Clin Breast Cancer. 2019 Jul 11;20(1):e27–e35. doi: 10.1016/j.clbc.2019.06.009

Figure 1.

Figure 1

a. Kaplan Meier curve summarizes the timeliness of care of the 45-day time-to-surgery benchmark. The number of patients who had not received surgery over time is presented at the bottom of the figure. At day 45, 77% of patients who had surgery as the first recommended treatment received surgery. b. Kaplan Meier curve summarizes the timeliness of care of the 1-year (yr) time-to-hormone therapy benchmark. Median day (25th- 75th %). The number of patients who had not started hormone therapy over time is presented at the bottom of the figure. At 1 yr, 97% of patients who were stage I-III and hormone receptor-positive started the hormone therapy.